MARC HOROWITZ to Survival Rate
This is a "connection" page, showing publications MARC HOROWITZ has written about Survival Rate.
Connection Strength
0.055
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.023
-
The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol. 1999 04; 1(2):152-61.
Score: 0.007
-
Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg. 1998 Apr; 28(4):215-22.
Score: 0.007
-
Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Pediatric Oncology Group. Pediatr Neurosurg. 1995; 22(4):189-96.
Score: 0.005
-
Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993 Jun 17; 328(24):1725-31.
Score: 0.005
-
Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res. 1991 Sep; (270):8-14.
Score: 0.004
-
Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J Clin Oncol. 1991 Apr; 9(4):600-5.
Score: 0.004